Galectin Therapeutics Inc GALT:NASDAQ

RT Quote | USD
Last | 05/08/24 EDT
3.24quote price arrow down-0.11 (-3.28%)
Volume
137,509
52 week range
1.28 - 4.27
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.35
  • 52 Week High4.27
  • 52 Week High Date04/12/24
  • 52 Week Low1.28
  • 52 Week Low Date06/26/23

Key Stats

  • Market Cap200.568M
  • Shares Out61.90M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta0.70
  • YTD % Change95.18

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.35
  • 52 Week High4.27
  • 52 Week High Date04/12/24
  • 52 Week Low1.28
  • 52 Week Low Date06/26/23
  • Market Cap200.568M
  • Shares Out61.90M
  • 10 Day Average Volume0.17M
  • Dividend-
  • Dividend Yield-
  • Beta0.70
  • YTD % Change95.18

RATIOS/PROFITABILITY

  • EPS (TTM)-0.74
  • P/E (TTM)-4.37
  • Fwd P/E (NTM)-4.91
  • EBITDA (TTM)-38.072M
  • ROE (TTM)-909.03%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-119.09%

EVENTS

  • Earnings Date05/13/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Galectin Therapeutics Inc

 

Profile

MORE
Galectin Therapeutics, Inc. is a clinical stage biopharmaceutical company dedicated to developing novel therapies to improve the lives of patients with chronic liver disease and cancer. The Company's drug candidates are based on its method of targeting galectin proteins, which are key mediators of biologic and pathologic functions. The Company's lead drug, belapectin, is a carbohydrate-based drug that inhibits the galectin-3 protein, which is directly involved in multiple...
Richard Uihlein
Independent Chairman of the Board
Joel Lewis CPA
President, Chief Executive Officer, Director
Jack Callicutt CPA
Chief Financial Officer
Address
SUITE 240
4960 PEACHTREE INDUSTRIAL BOULEVARD
Norcross, GA
30071
United States

Top Peers

SYMBOLLASTCHG%CHG
ATOS
Atossa Therapeutics Inc
1.68-0.02-1.18%
TRVI
Trevi Therapeutics Inc
2.64-0.26-8.97%
ABOS
Acumen Pharmaceuticals Inc
3.40+0.04+1.19%
DSGN
Design Therapeutics Inc
4.69UNCHUNCH
ELEV
Elevation Oncology Inc
3.58+0.10+2.87%